Sustained-release naltrexone: novel treatment for opioid dependence.
about
Sustained-Release Naltrexone For Opioid DependenceMedications development for opioid abuseImproving clinical outcomes for naltrexone as a management of problem alcohol useMarketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid OverviewAgonist Medications for the Treatment of Cocaine Use DisorderA placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.A stress-coping profile of opioid dependent individuals entering naltrexone treatment: a comparison with healthy controlsDrug users' adherence to a 6-month vaccination protocol: effects of motivational incentives.Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence.Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy.Clinical safety of 1500 mg oral naltrexone overdose.Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.Early outcomes following low dose naltrexone enhancement of opioid detoxification.Patterns in admission delays to outpatient methadone treatment in the United StatesNaltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys.Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial.Use of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine AddictionAfrican American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patientsThe use of incentives to reinforce medication adherence.Maintenance of reinforcement to address the chronic nature of drug addiction.Factors associated with willingness to take extended release naltrexone among injection drug users.Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.Novel medications to treat addictive disordersNaltrexone extended-release injection: an option for the management of opioid abuse.A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.Manifold implications of forgotten hyperglycemia in clinical opiate dependence.Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.Long-acting Preparations in Substance Abuse Management: A Review and Update.Novel Pharmacologic Approaches to Treating Cannabis Use Disorder.Animal models for opioid addiction drug discovery.Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Narrowing in on compulsions: dopamine receptor functions.Favorable mortality profile of naltrexone implants for opiate addiction.Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use.Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.
P2860
Q24243205-16305DD6-8E37-453C-9F90-C704383A8F92Q26853370-06B3E4FE-CBE9-4E1B-94C4-065D4737529EQ27021406-6D309E7F-45DC-4B38-9155-713420BB7E48Q28079382-B7539FBC-6881-4AB0-9424-48AB9FC0ADE8Q28087404-19720030-3C6D-4668-8A06-A58A4EEFFCC5Q33556479-78590872-6A62-4FAB-8617-11E5856D45F5Q33574825-8E2392D8-821E-449D-AFED-8607FE68502EQ33625219-571DDA93-8AC5-4681-9D2B-EB7F4F7F08D3Q34513344-31A00573-F831-4DFF-A6B5-FAB940BD49EDQ34525271-A2D29CB4-6855-49A1-AA15-E0E284D4D36CQ34526419-C8538334-E7FA-42F9-91F8-D6AADD41693CQ35023989-3DCAE8CD-9C07-473F-B57B-4402E6651264Q35090939-64C34C40-1AC9-4574-B627-5AC125B44433Q35220086-42C84C6A-FB84-4F5D-A2C0-1A68DC5341B8Q35303819-0B16098A-BC67-43BF-903B-B6069E23B2AAQ35490594-206A1884-CA3A-4C6E-B3AF-549670C601CEQ35599780-A8F89FB6-8885-4188-8EA7-0B39B7D79CB2Q35633106-AA58F434-6BAB-4B16-AF80-886986BF6ED5Q35636912-080E8E21-7FAE-4063-B14C-54C1D1AB4AA8Q35653149-C6CDB66F-8506-447A-90A2-CCF627B9C797Q36179591-9674A132-217F-41A3-90EA-88981DAC6317Q36218625-01314EDD-2B41-4B0A-93D0-6F8AECF49152Q36259160-DD31B189-83A7-4D74-8450-5CDB2AD89AFAQ36300075-4592F12D-C3C8-4ADF-874D-2E966A9CEC14Q36808909-B5918188-10EF-4DBB-82B1-B8F52C1B2E6BQ37029633-0AEFE103-0964-4351-AD08-203711644342Q37355293-D3D53D6E-E8D8-4CEE-B0C1-4A0145AB95B1Q37570243-9FED0A77-5E13-4802-8DF4-EF4EAE0F404EQ37982128-321772EE-347C-4C5A-B563-3ABC7F3ED591Q37999447-32EBE1DC-2918-4A05-B9BA-67E946719006Q38119942-92DF675F-7A03-48E1-B9EC-84F7A77E3A9BQ38222436-ECFE8AD3-CA0E-4341-BC4D-B8DA99B316CBQ38259272-16F62757-A057-4512-9C85-84A33710AB08Q38373652-0DBF6907-99DE-4DA3-BB52-84EEDE00F67FQ39034288-88DF0367-79DF-4B15-A099-4767EF30FC95Q42185512-A7E50554-A0D0-4395-BA05-805DD9FEFA93Q43100374-354B6D44-A8DE-49CC-A3CB-15774845E0F6Q45089599-288FC71B-684D-498A-898B-841CE5E4ABEBQ46426017-A9F3F70E-1FFF-49F1-B0C0-C1B88ED87DF7Q47384878-BAC04057-5F7C-415E-B25D-D159E68F5DE8
P2860
Sustained-release naltrexone: novel treatment for opioid dependence.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Sustained-release naltrexone: novel treatment for opioid dependence.
@ast
Sustained-release naltrexone: novel treatment for opioid dependence.
@en
Sustained-release naltrexone: novel treatment for opioid dependence.
@nl
type
label
Sustained-release naltrexone: novel treatment for opioid dependence.
@ast
Sustained-release naltrexone: novel treatment for opioid dependence.
@en
Sustained-release naltrexone: novel treatment for opioid dependence.
@nl
prefLabel
Sustained-release naltrexone: novel treatment for opioid dependence.
@ast
Sustained-release naltrexone: novel treatment for opioid dependence.
@en
Sustained-release naltrexone: novel treatment for opioid dependence.
@nl
P2093
P2860
P1476
Sustained-release naltrexone: novel treatment for opioid dependence.
@en
P2093
Gary K Hulse
Maria A Sullivan
Sandra D Comer
P2860
P304
P356
10.1517/13543784.16.8.1285
P407
P577
2007-08-01T00:00:00Z